(Sharecast News) - Life science research tool specialist Abcam updated the market on the cancellation of its shares on AIM on Monday, which it first announced on 17 October.
The AIM-traded firm confirmed that the last day of trading of its ordinary shares on AIM would be 13 December.
After that, the proposed delisting from AIM would be effective from 0700 GMT on 14 December.
"Abcam will retain the listing of its American depositary shares, each representing one ordinary share, on Nasdaq under the ticker symbol ABCM," the board said in its statement.
"Following the AIM delisting, the company's ADSs will remain listed, and will only be tradeable, on Nasdaq."
At 1135 GMT, shares in Abcam were down 3.44% in London at 1,180p.
Reporting by Josh White for Sharecast.com.
